NRXS — Neuraxis, INC

NYSE · Health Care · Health Care Equipment & Supplies · CIK 1933567 ·
Last close
$6.07
Market Cap
$76.23M
52W High
$7.69
52W Low
$5.50
ADV30
90,594
Next earnings
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 1,607,883 1,389,517 -1,740,679 -1,761,432 8,745,706 7,078,659 2,998,156
Dec 2025 968,127 826,476 -1,716,868 -1,708,657 6,404,036 4,965,072 3,004,664
Sep 2025 811,414 675,927 -2,100,085 -2,122,796 5,776,363 4,377,109 3,491,422
Jun 2025 894,086 747,443 -1,717,858 -1,690,418 7,087,999 5,988,456 2,834,705

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-6,058,945
Investing CF
$-113,150
Financing CF
$11,245,384
CapEx
$-131,150
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.97
As of
2026-08-16

Balance + Analyst (yfinance extras)

Retained Earnings
$-66,361,599
Inventory
$238,282
Receivables
$385,009
ST Investments
EBIT TTM
$-7,185,383
Pretax Income TTM
$-7,283,303
Interest Exp TTM
$97,920
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$5,316,119
EBITDA
$-7,609,116
Free Cash Flow
$-3,154,924
Enterprise Value
$69,191,184
Total Cash
$8,322,258
Total Debt
$279,392
Shares Out
12,557,765
Trailing EPS
$-0.76
Book Value
$0.54
ROE
-139.8%
ROA
-56.2%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 3,569,282 -7,829,908 -7,800,555 6,404,036 3,004,664 -6,432,843
Dec 2024 2,685,925 -7,156,817 -8,241,501 4,757,572 2,689,824 -6,098,264
Dec 2023 2,460,049 -6,664,495 -14,626,683 509,498 1,912,739 -6,693,978
Dec 2022 2,684,735 -3,372,238 -4,780,061 1,480,644 7,054,257 -2,298,004

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.27

Peers — same industry

TickerNameMarket CapLastDaily %
RTGN RetinalGenix Technologies Inc. $75.37M $4.00
HYPR Hyperfine, Inc. $77.92M $0.86
OM Outset Medical, Inc. $78.76M $4.19
DRIO DarioHealth Corp. $70.65M $7.21
CVRX CVRx, Inc. $83.92M $3.15

News headlines (Yahoo Finance, 1h cache)

NRXS Stock Dips Post Q2 Earnings Despite Revenue Surge, Gross Margin Up
2026-08-14 15:42 · Yahoo
Neuraxis Inc (NRXS) (Q2 2026) Earnings Call Highlights: Revenue Surges 116% as Payer Coverage ...
2026-08-11 21:00 · Yahoo
NeurAxis Reports Record Second Quarter 2026 Financial Results Driven by 116% Year Over Year Revenue Growth
2026-08-11 11:05 · Yahoo
NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y
2026-05-15 16:23 · Yahoo
Neuraxis Inc (NRXS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Coverage Challenges
2026-05-12 23:01 · Yahoo
NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026
2026-05-05 11:00 · Yahoo
NeurAxis Expands Payer Coverage with Four New Medical Policies
2026-04-22 11:00 · Yahoo
NeurAxis, Inc. Announces Preferred Stock Dividend
2026-04-10 11:00 · Yahoo
The Zacks Analyst Blog Highlights Alphabet, Walmart, Micron Technology and NeurAxis
2026-05-05 10:34 · Yahoo
NeurAxis, Inc. Q2 2026 Earnings Call Summary
2026-08-12 02:52 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.